4th Quarter - Report
TIBER CREEK GROUP for ROIVANT SCIENCES, INC.
Firm
Client
Income
$70,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Telecommunications TEC
Issues pertaining to telemedicine and implementation of Special Registration rule. Implementation of SUPPORT for Patients and Communities Act (Public Law No: 115-271).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
| MATTHEW LEFFINGWELL | — |
| ANDREW MCKECHNIE | — |
| JENNIFER OLSON | — |
| JEFFREY SHAPIRO | — |
Health Issues HCR
Treatment of diabetes, development of gene therapies, telemedicine
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
| MATTHEW LEFFINGWELL | — |
| ANDREW MCKECHNIE | — |
| JENNIFER OLSON | — |
| JEFFREY SHAPIRO | — |
Pharmacy PHA
Treatment of diabetes, development of gene therapies
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
| MATTHEW LEFFINGWELL | — |
| ANDREW MCKECHNIE | — |
| JENNIFER OLSON | — |
| JEFFREY SHAPIRO | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ROIVANT SCIENCES LTD. | Bermuda | United Kingdom | 100.0% | — |
| ROIVANT SCIENCES GMBH | Switzerland | Switzerland | — | — |
| ROIVANT SCIENCES HOLDINGS LTD. | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.